DEFINITIVE PROXY STATEMENT

Company

Eloxx Pharmaceuticals, Inc.

Filed

October 27, 2006

Period of Report

December 14, 2006

Accession Number

0001104659-06-069121

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →